利益与风险的权衡以及患者对性结肠炎治疗选择的偏好:一项多国偏好研究
Javier P Gisbert1,2, Stefan Schreiber3, Corey A Siegel4,5
1Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Inflammatory bowel diseases
|August 10, 2024
概括
性结肠炎 (UC) 患者优先考虑临床缓解,接受有效治疗的稍高风险. 这种以患者为中心的方法有利于像菲尔戈提尼布这样的治疗,而不是安慰剂.
科学领域:
- 胃肠病学 胃肠病学
- 药物经济学 药物经济学
- 患者报告的结果.
背景情况:
- 性结肠炎 (UC) 呈现出一个复杂的治疗环境.
- 量化患者的利益风险权衡对于治疗选择至关重要.
研究的目的:
- 量化患者愿意接受性结肠炎治疗效益的风险.
- 评估患者对治疗特征的偏好及其对决策的影响.
主要方法:
- 在五个欧洲国家与631名UC患者进行了在线离散选择实验.
- 通过临床数据,文献和患者访谈确定了治疗属性.
- 计算了相对属性重要性 (RAI) 评分和最大可接受风险.
主要成果:
- 临床缓解是患者的主要优先事项 (RAI 32.4%).
- 患者接受了血液凝块,感染和恶性瘤的风险略有增加.
- 口服,避免使用类固醇和维持日常活动也受到重视.
结论:
- 实现和维持临床缓解是UC患者的首要目标.
- 患者愿意接受一定风险的适度增加以实现缓解.
- 患者偏好数据表明,他们更喜欢使用菲尔戈提尼布而不是安慰剂的可能性很大.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
133
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
133
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
Inflammatory Bowel Disease V: Surgical Management
134
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
134
Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156


